Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eduardo L. Setti is active.

Publication


Featured researches published by Eduardo L. Setti.


Bioorganic & Medicinal Chemistry Letters | 2003

3,4-Disubstituted Azetidinones as Selective Inhibitors of the Cysteine Protease Cathepsin K. Exploring P2 Elements for Selectivity

Eduardo L. Setti; Dana E. Davis; Tobee Chung; John McCarter

A novel series of 3,4-disubstituted azetidinones based inhibitors of the cysteine protease cathepsin K (Cat K) has been identified. Although not optimized, some of these compounds show at least 100-fold selectivity against other cathepsins. The use of cyclic moieties as P2 elements has proven to be crucial to achieve a high degree of selectivity.


Bioorganic & Medicinal Chemistry Letters | 1997

Studies on penam sulfones III. Synthesis and β-lactamase inhibitory activity of sodium (6R)-6-(α-hydroxybenzyl)-2β-methoxyiminomethyl-2α-methylpenam-3α-carboxylate 1,1-dioxide and sodium 2β-acyl-2α-methylpenam-3α-carboxylate 1,1-dioxide

David P. Czajkowski; Andhe V. Narender Reddy; Eduardo L. Setti; Oludotun A. Phillips; Ronald G. Micetich; Chieko Kunugita; Samarendra N. Maiti

Abstract The synthesis and in vitro synergies of (6R)-6-(α-hydroxybenzyl)-2β-methoxyiminomethyl-2α-methylpenam-3α-carboxylate 1,1-dioxide ( 4 ) and 2β-acyl-2α-methylpenam-3α-carboxylate 1,1-dioxide ( 15 ) are described. Compound 15 showed good in vitro synergy in combination with piperacillin and ceftazidime against chromosomally mediated class I cephalosporinase producing organisms including TEM, SHV, and OXA-type enzymes producing microorganisms.


Chemistry of Heterocyclic Compounds | 1998

Studies on monobactams II. Synthesis and β-lactamase inhibitory activity of 4α-methyl-3-[(thien-2-yl)-methylene]-2-azetidinone-1-sulfonate

Oludotun A. Phillips; Eduardo L. Setti; Andhe V. Narender Reddy; Ronald G. Micetich; Chieko Kunugita; Akio Hyodo; Samarendra N. Maiti

Two monobactam derivatives, potassium 4α-methyl-(3E)-[(thien-2-yl)methylene]-2-azetidinone-1-sulfonate and its (3Z)-isomer, were prepared and evaluated for their β-lactamase inhibitory activities. These compounds were devoid of β-lactamase inhibitory activity.


Archive | 2000

Compounds and compositions as protease inhibitors

Clifford M. Bryant; James T. Palmer; Robert M. Rydzewski; Eduardo L. Setti; Zong-Qiang Tian; Shankar Venkatraman; Dan-Xiong Wang


Journal of Medicinal Chemistry | 2005

Design and Synthesis of Tri-Ring P3 Benzamide-Containing Aminonitriles as Potent, Selective, Orally Effective Inhibitors of Cathepsin K

James T. Palmer; Clifford Bryant; Dan-Xiong Wang; Dana E. Davis; Eduardo L. Setti; Robert M. Rydzewski; Shankar Venkatraman; Zong-Qiang Tian; Leland C. Ii Burrill; Rohan Mendonca; Eric Springman; John McCarter; Tobee Chung; Harry Cheung; James W. Janc; Mary E. McGrath; John R. Somoza; Philip Enriquez; Z. Walter Yu; Robert M. Strickley; Liang Liu; Michael C. Venuti; M. David Percival; Jean-Pierre Falgueyret; Peppi Prasit; Renata Oballa; Denis Riendeau; Robert N. Young; Gregg Wesolowski; Sevgi B. Rodan


Journal of Medicinal Chemistry | 2003

A Novel Class of Nonpeptidic Biaryl Inhibitors of Human Cathepsin K

Joel Robichaud; Renata Oballa; Peppi Prasit; Jean-Pierre Falgueyret; M. David Percival; Gregg Wesolowski; Sevgi B. Rodan; Donald B. Kimmel; Colena Johnson; Cliff Bryant; Shankar Venkatraman; Eduardo L. Setti; Rohan Mendonca; James T. Palmer


Journal of Medicinal Chemistry | 2006

Beta-substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin K.

Sheldon N. Crane; W. Cameron Black; James T. Palmer; Dana E. Davis; Eduardo L. Setti; Joel Robichaud; Julie Paquet; Renata Oballa; Christopher I. Bayly; Daniel J. McKay; John R. Somoza; Natalie Chauret; Carmai Seto; John Scheigetz; Greg Wesolowski; Frédéric Massé; Sylvie Desmarais; Marc Ouellet


Archive | 1997

AZETIDINONE DERIVATIVES AS β-LACTAMASE INHIBITORS

Samarendra N. Maiti; Oludotun A. Phillips; Eduardo L. Setti; Andhe V. Narender Reddy; Ronald G. Micetich; Fusahiro Higashitani; Chieko Kunugita; Koichi Nishida; Tatsuya Uji


Archive | 1998

2-oxo-1-azetidine sulfonic acid derivatives as potent beta-lactamase inhibitors

Samarendra N. Maiti; Eduardo L. Setti; Oludotun A. Phillips; Andhe V. Narender Reddy; Ronald G. Micetich; Rajeshwar Singh; Fusahiro Higashitani; Chieko Kunugita; Koichi Nishida; Tatsuya Uji


Bioorganic & Medicinal Chemistry Letters | 2006

Design and synthesis of tetracyclic nonpeptidic biaryl nitrile inhibitors of cathepsin K.

Eduardo L. Setti; Shankar Venkatraman; James T. Palmer; Xiaoming Xie; Harry Cheung; Walter Yu; Gregg Wesolowski; Joel Robichaud

Collaboration


Dive into the Eduardo L. Setti's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge